Practically: if you have type 2 diabetes, are insulin resistant, or have a strong family history of type 2 diabetes, CJC-1295 is not an automatic no, but it changes your monitoring obligations substantially
The market is anticipated to register a CAGR of 6.9% during 20252031
Compounded Semaglutide may cause mild side effects like nausea, stomach upset, or headaches, similar to the brand-name versions
Public Comment Closes on the FDA Plan to Permanently Bar Bulk Compounding of Semaglutide and Tirzepatide The window for the public to weigh in on whether large compounding facilities should ever again be allowed to make semaglutide and tirzepatide from raw ingredients closed at 11:59 p.m
GLP-1 drugs also seem to have anti-addictive properties some users report that they have fewer cravings for alcohol or have become less likely to engage in other addictive behaviors, such as gambling, shopping, or nail-biting
Pay attention to your skin's appearance and feel
